HIGHLIGHTS
- who: Sher Singh and Ying-Fei Yang from the Department of Life Science, School of Life Science, College of Science, National Taiwan Normal University have published the paper: Pharmacological Mechanism of NRICM101 for COVID-19 Treatments by Combined Network Pharmacology and Pharmacodynamics, in the Journal: (JOURNAL) of 24/Nov/2022
- what: This study thus provides the first thorough pharmacogenomic analysis of NRICM101 incorporated with the PD analyses such that the underlying drug-gene or drug-protein mechanisms and molecular pathways associated with disease onsets were explored.
- how: Showed that there were 434 common . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.